Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB271460PCP

ITM2B Antibody (OTI1C11), PerCP, Novus Biologicals™
SDP

Catalog No. NB271460PCP Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB271460PCP 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB271460PCP Supplier Novus Biologicals Supplier No. NBP271460PCP
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

ITM2B Monoclonal specifically detects ITM2B in Human, Mouse, Rat samples. It is validated for Flow Cytometry.

Specifications

Antigen ITM2B
Applications Flow Cytometry
Classification Monoclonal
Clone OTI1C11
Conjugate PerCP
Dilution Flow Cytometry
Formulation PBS with 0.05% Sodium Azide
Gene Alias ABRI, ABri/ADan amyloid peptide, BRI2, BRICD2B, BRICHOS domain containing 2B, BRIFBD, E25B, E3-16, integral membrane protein 2B, Protein E25B, Transmembrane protein BRI
Gene Symbols ITM2B
Host Species Mouse
Immunogen Full length recombinant protein of human ITM2B (NP_068839) produced in HEK293T cells.
Purification Method Affinity Purified
Quantity 0.1 mL
Research Discipline Neuroscience, Signal Transduction
Primary or Secondary Primary
Gene ID (Entrez) 9445.0
Target Species Human, Mouse, Rat
Content And Storage Store at 4°C in the dark.
Isotype IgG2a
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.